1Bachmeier BF,Nerlich AG,Lichtinghagen R,et al.Matrix metalloproteinases(MMP)In breast cancer cell lines of different tumorigenicity.Anticancer Res,2001,21(6A):3821-3828. 被引量：1
2Ranuncolo SM,Armanasco E,Cresta C,et al.Plasma MMP-9(92kDa-MMP)activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients.Int J Cancer,2003;106(5):745-751. 被引量：1
3Nakopoulou L,Tsirmpa I,Alexandrou P,et al.MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival.Breast Cancer Res Treat,2003;77(2):145-155. 被引量：1
4Talvensaari Mattila A,Paakko P,Turpeenniemi-Hujanen T.Matrix metal loproteinase-2(MMP-2)is associated with survival in breast cancer.Br J Cancer,2003;89(7):1270-1275. 被引量：1
5Schrohl AS,Holten Andersen MN,Peters HA,et al.Tumor tissuelevels of tissue inhibitor of metalloproteinase Ⅰ asaprognostic marker in primary breast cancer.Clin Cancer Res,2004;10(7):2289-2298. 被引量：1
6Hansen S, Grabau DA,Sorensen FB,et al. Vascular grading of angiogenesis: prognostic significance in breast cancer. Br J Cancer 2000 ; 82(2) : 339 - 347. 被引量：1
7Ferrara N, Gerber HP, Le Couter J. The biology of VEGF and its receptors. Nat Med,2003 ; 9 : 669. 被引量：1
8Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer, 2003; 98 (2), 413 - 423. 被引量：1
9Toi M, Bando H, Ogawa T, et al. Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor- 1 relationship in breast cancer. Int J Cancer, 2002; 98( 1 ) : 14 -18. 被引量：1
10Toi M, Hoshina S, Takayanagi T, et al. Association of vascular endothelial growth factor expression With tumor angiogenesis and with early relapse in primary breast Cancer. Jpn J Cancer Res 1994 ; 85 : 104510495. 被引量：1
